Seroepidemiology of toxoplasma gondii in kidney transplant patients
- PMID: 40786582
- PMCID: PMC12329353
- DOI: 10.22088/cjim.16.3.507
Seroepidemiology of toxoplasma gondii in kidney transplant patients
Abstract
Background: Opportunistic infection after transplantation is a serious problem, with Toxoplasma Gondii (T.gondii) and cytomegalovirus being the most concerning infections. The objective of this research was to examine the seroepidemiology of the T. gondii virus among kidney transplant recipients at Sina Hospital in Tehran from 2017 to 2021.
Methods: A total of 342 kidney transplant patients participated in this cross-sectional study using the census method after obtaining consent. Data were collected by reviewing medical records and the transplant database, including demographic characteristics and infectious tests related to kidney transplantation. The collected information was entered into SPSS18 software.
Results: The age of the subjects ranged from 10 to 73 years, with 125 patients having kidney failure due to ERDS. The rate of exposure to T. gondii in kidney transplant patients was 54.2%. 125 patients experiencing kidney failure due to ERDS. In kidney transplant patients, the exposure rate to T. gondii was 54.2%. There is a positive correlation between TOX IgG and age (r= 0.12, P = 0.02). There is a positive correlation between CMV IgG and the time elapsed since kidney transplantation (r = 0.11, P = 0.03) and TOX IgG (r = 0.13, p < 0.01). Gender was found not to predict EBV.IgG (β = 0.787, p < 0.21), CMV.IgG (β = 4.752, p < 0.071), TOX.IgG (β = 1.154, p < 0.256) based on regression tests.
Conclusion: Physicians should be aware of preventive measures and should consider early diagnosis in cases of compatible symptoms. Screening for anti-Toxoplasma IgM antibodies in potential donors is recommended.
© The Author(s).
Conflict of interest statement
None.
Similar articles
-
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2. Cochrane Database Syst Rev. 2024. PMID: 39698949
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
[Retrospective evaluation of serologic and molecular test results of toxoplasmosis suspected patients].Mikrobiyol Bul. 2019 Jan;53(1):96-105. doi: 10.5578/mb.67469. Mikrobiyol Bul. 2019. PMID: 30683043 Turkish.
-
Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients.Cochrane Database Syst Rev. 2024 Nov 28;11(11):CD014839. doi: 10.1002/14651858.CD014839.pub2. Cochrane Database Syst Rev. 2024. PMID: 39606952
References
-
- Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14:1089–101. - PubMed
-
- Putignani L, Mancinelli L, Del Chierico F, et al. Investigation of Toxoplasma gondii presence in farmed shellfish by nested-PCR and real-time PCR fluorescent amplicon generation assay (FLAG) Exp Parasitol. 2011;127:409–17. - PubMed
-
- Demar M, Ajzenberg D, Maubon D, et al. Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin Infect Dis. 2007;45:e88–95. - PubMed
LinkOut - more resources
Full Text Sources